Načítá se...
1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
BACKGROUND: Trimethoprim sulfamethoxazole (TMP-SMX) is the preferred agent for Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised hosts (ICH). However, TMP-SMX is frequently avoided due to an adverse drug reaction (ADR) history. We report on a novel multicentre programmatic approach t...
Uloženo v:
| Vydáno v: | Open Forum Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6252477/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1406 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|